Vaupell Midwest04.16.20
Vaupell Midwest, a manufacturer of complex molded parts and assemblies, announced its MedAccred Accreditation. MedAccred (based on the Nadcap accreditation program for the aerospace industry) is a worldwide medical device industry collaborative oversight program designed to provide superior quality manufacturing supply-chain oversight for OEMs looking to partner with Contract Manufacturers.
This deep-dive, single-audit criteria program utilizes cost-effective approaches to managing processes, product manufacturing, reducing waste and rework, and testing specifications between OEMs and relevant CMs. This single robust program administered by the Performance Review Institute (PRI) provides continuous improvement results, minimizes supplier risk, and reduces some of the routine OEM supplier critical audits, all geared to enhance patient safety.
Some of the OEMs participating in this program are Bausch Health, Baxter, Bayer, BD, Boston Scientific, Flex, Johnson & Johnson, Medtronic, Philips, Roche Diagnostics, and Stryker.
“At Vaupell, we have always been extremely process-oriented. We employ a disciplined approach to injection molding using Scientific Injection Molding (SIM). We are a data-driven organization in all we do, and we have a continuous improvement approach to delivering on the quality expectations of our customers in the medical device industry,” said Keith Bridgford, Plant Manager, Vaupell Midwest. “We highly value the needs of our OEM partners and understand the need for a single-audit criteria program that improves patient safety and ensures superior manufacturing best practices.”
“The audit process dove-tailed very nicely with the processes that we already had in place,” said Jessica Arseneau, Quality Manager, Vaupell Midwest. “It allowed us the opportunity to do a full gap assessment of the current and target state of our processes, practices, capabilities, documentation control, and quality systems to better align and simplify the ongoing critical audit process for our long-term OEM partners.”
This deep-dive, single-audit criteria program utilizes cost-effective approaches to managing processes, product manufacturing, reducing waste and rework, and testing specifications between OEMs and relevant CMs. This single robust program administered by the Performance Review Institute (PRI) provides continuous improvement results, minimizes supplier risk, and reduces some of the routine OEM supplier critical audits, all geared to enhance patient safety.
Some of the OEMs participating in this program are Bausch Health, Baxter, Bayer, BD, Boston Scientific, Flex, Johnson & Johnson, Medtronic, Philips, Roche Diagnostics, and Stryker.
“At Vaupell, we have always been extremely process-oriented. We employ a disciplined approach to injection molding using Scientific Injection Molding (SIM). We are a data-driven organization in all we do, and we have a continuous improvement approach to delivering on the quality expectations of our customers in the medical device industry,” said Keith Bridgford, Plant Manager, Vaupell Midwest. “We highly value the needs of our OEM partners and understand the need for a single-audit criteria program that improves patient safety and ensures superior manufacturing best practices.”
“The audit process dove-tailed very nicely with the processes that we already had in place,” said Jessica Arseneau, Quality Manager, Vaupell Midwest. “It allowed us the opportunity to do a full gap assessment of the current and target state of our processes, practices, capabilities, documentation control, and quality systems to better align and simplify the ongoing critical audit process for our long-term OEM partners.”
